INDIA: Drugs Sold over the Counter Fuel HIV in India

Important note: Information in this article was accurate in 2006. The state of the art may have changed since the publication date.

INDIA: Drugs Sold over the Counter Fuel HIV in India

Reuters (12.11.06) - Monday, December 18, 2006

Injection drug users (IDUs) in India are easily circumventing prescription laws for pain medications and sedatives, resulting in an informal market that is raising HIV risks, UNAIDS reported recently. Though by law many painkillers and sedatives require a prescription, these are nevertheless sometimes sold over the counter in India.

"The problem is the implementation of the law," Suresh Kumar, an advisor to UNAIDS and the World Health Organization, told a news conference. "[There] are too few drug inspectors, and drug users shift to pharmaceutical preparations that are readily available."

IDUs are buying the painkillers, crushing them and suspending their ingredients in a solution they inject. They often share needles, which easily spreads HIV.

"Intravenous drug transmission may be a small part of overall transmission, but it can be a turbo engine for accelerating the epidemic," said Swaroop Sarkar, UNAIDS regional advisor. Currently, 2.6 percent of HIV infections in India are IDU- related, said officials.

For many South Asian drug users, a few years elapse between using inhalants, progressing to snorting, and then to injecting drugs, said experts. "This is a window of opportunity to intervene and prevent people from crossing over into injecting drug use," said Gordon Mortimore, head of the Program Management Office of Britain's Department for International Development-India.
061218
AD062446

Copyright © 2006 - Information, Inc., Bethesda, MD. The CDC National Center for HIV, STD and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Elton John AIDS Foundation, the National Library of Medicine, AIDS Walk of Orange County, and donations from users like you.

Always watch for outdated information. This article first appeared in 2006. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2006. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content.